Particle.news
Download on the App Store

Johann Lafer Reveals Ongoing Chemotherapy for Indolent Non‑Hodgkin Lymphoma

The family says the treatment has cut the visible tumors by about half under care at Uniklinik Mainz.

Overview

  • Lafer publicly disclosed his diagnosis in late May after enlarged lymph nodes were monitored since early 2024 and doctors recommended systemic therapy when they grew.
  • He began chemotherapy in January 2026 and has completed multiple cycles with the family reporting a roughly 50% reduction in the lymphomas on recent follow-up.
  • Treatment has produced clear side effects, including an estimated 25 kilogram weight loss and hair loss, which the family says are temporary and expected to recover.
  • Silvia Lafer has spoken to the press about caregiving, the couple’s choice to delay telling their adult children, and her confidence in the Uniklinik Mainz team and the prognosis.
  • Lafer has resumed selective public appearances and social posts while continuing outpatient treatment, and physicians plan further follow-up to monitor response and side effects.